Xtant Medical Holdings, Inc. (XTNT)

Market Cap	68.06M
Revenue (ttm)	117.27M
Net Income (ttm)	-16.45M
Shares Out	139.07M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,356
Open	0.4984
Previous Close	0.5000
Day's Range	0.4700 - 0.5097
52-Week Range	0.3300 - 1.2400
Beta	0.41
Analysts	Strong Buy
Price Target	3.00 (+488.58%)
Earnings Date	Mar 6, 2025

About XTNT

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the oste...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Sean Browne
• Employees: 232
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: XTNT
• Website: https://www.xtantmedical.com

Analyst Forecast

According to one analyst, the rating for XTNT stock is "Strong Buy" and the 12-month stock price forecast is $3.0.

Price Target

$3.0

(488.58% upside)

Analyst Consensus: Strong Buy